News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,829 Results
Type
Article (216)
Company Profile (1)
Press Release (10626)
Section
Business (6697)
Career Advice (8)
Deals (778)
Drug Delivery (1)
Drug Development (773)
Employer Resources (1)
FDA (98)
Job Trends (257)
News (7498)
Policy (193)
Tag
Academia (11)
Accelerated approval (1)
ADA (1)
Allergies (3)
Alliances (164)
ALS (5)
Alzheimer's disease (18)
Antibody-drug conjugate (ADC) (9)
Approvals (119)
Artificial intelligence (3)
ASCO (5)
Autoimmune disease (7)
Bankruptcy (3)
Best Places to Work (265)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (6)
Breast cancer (20)
Cancer (132)
Cardiovascular disease (14)
Career advice (7)
CAR-T (3)
CDMO (1)
Cell therapy (12)
Cervical cancer (1)
Clinical research (842)
Collaboration (19)
Commercialization (1)
Compensation (12)
Complete response letters (2)
COVID-19 (28)
C-suite (21)
Cystic fibrosis (2)
Data (220)
Depression (2)
Dermatology (3)
Diabetes (13)
Diagnostics (125)
Digital health (4)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (18)
Earnings (7397)
Employer resources (1)
Events (584)
Executive appointments (10)
FDA (251)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (22)
Gene therapy (4)
GLP-1 (15)
Government (27)
Guidances (96)
Healthcare (392)
Hematology (2)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (5)
Immuno-oncology (3)
Indications (2)
Infectious disease (38)
Inflammatory bowel disease (2)
Influenza (7)
Intellectual property (8)
IPO (684)
Job creations (14)
Job search strategy (6)
Kidney cancer (2)
Labor market (1)
Layoffs (1)
Leadership (1)
Legal (20)
Licensing (1)
Liver cancer (2)
Lung cancer (28)
Lymphoma (9)
Manufacturing (9)
MASH (5)
Medical device (331)
Medtech (338)
Mergers & acquisitions (107)
Metabolic disorders (27)
Multiple sclerosis (4)
Neurodegenerative disease (9)
Neuropsychiatric disorders (2)
Neuroscience (56)
NextGen: Class of 2026 (77)
Non-profit (19)
Obesity (5)
Opinion (1)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (5)
Parkinson's disease (13)
Patents (5)
Patient recruitment (9)
People (175)
Pharmacy benefit managers (1)
Phase 1 (174)
Phase 2 (340)
Phase 3 (390)
Pipeline (653)
Policy (1)
Postmarket research (39)
Preclinical (42)
Prostate cancer (5)
Radiopharmaceuticals (5)
Rare diseases (23)
Real estate (12)
Recruiting (1)
Regulatory (232)
Reports (4)
Research institute (12)
Resumes & cover letters (1)
Rett syndrome (3)
RSV (1)
Schizophrenia (5)
Series A (1)
Series B (3)
Sickle cell disease (4)
Spinal muscular atrophy (4)
Sponsored (2)
Startups (6)
Stomach cancer (1)
Vaccines (20)
Venture capital (1)
Weight loss (6)
Women's health (3)
Date
Last 7 days (10)
Last 30 days (64)
Last 365 days (956)
2026 (667)
2025 (904)
2024 (935)
2023 (1075)
2022 (1150)
2021 (1047)
2020 (984)
2019 (633)
2018 (558)
2017 (356)
2016 (202)
2015 (336)
2014 (187)
2013 (125)
2012 (157)
2011 (218)
2010 (223)
Location
Africa (6)
Alabama (5)
Arizona (2)
Asia (597)
Australia (30)
California (397)
Canada (136)
China (31)
Colorado (25)
Connecticut (26)
Delaware (11)
Europe (1548)
Florida (59)
Georgia (23)
Illinois (54)
India (1)
Indiana (26)
Japan (16)
Kansas (3)
Kentucky (2)
Louisiana (9)
Maine (3)
Maryland (49)
Massachusetts (276)
Michigan (13)
Minnesota (22)
Missouri (2)
New Hampshire (3)
New Jersey (152)
New York (102)
North Carolina (56)
Northern California (216)
Ohio (11)
Pennsylvania (102)
South America (6)
Southern California (173)
Tennessee (5)
Texas (70)
United States (1588)
Utah (21)
Virginia (3)
Washington D.C. (1)
Washington State (76)
Wisconsin (4)
10,829 Results for "151".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
August 30, 2026
·
1 min read
Press Releases
Single-use Bioprocessing Market Size to Surpass USD 151.48 Bn by 2034
October 30, 2025
·
1 min read
Press Releases
MAIA Biotechnology Announces $1.51 Million Private Placement
December 17, 2025
·
4 min read
Press Releases
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 22, 2026
·
15 min read
Press Releases
Axon Neuroscience’s Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant
February 4, 2026
·
6 min read
Philips completes cancellation of 15.1 million shares
Royal Philips announced that it has completed the cancellation of 15,134,054 of its shares.
December 19, 2023
·
1 min read
BioMidwest
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series A funding, co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations.
December 8, 2022
·
4 min read
Press Releases
Progressive Pulmonary Fibrosis (PPF) Market Estimated to Reach USD 2,151.85 Million by 2034, Impelled by Advancements in Drug Development
August 5, 2024
·
12 min read
Deals
Curis Announces $15.1 Million Registered Direct Offering
Curis, Inc. today announced that it has entered into definitive agreements led by existing investors for the purchase of 18.4 million of its shares of common stock at a purchase price of $0.82 per share in a registered direct offering priced at-the-market under Nasdaq rules.
July 6, 2023
·
5 min read
Medical Device Contract Research Organization Market Size to Surpass US$ 15.1 BN by 2030
The Medical Device Contract Research Organization Market size is expected to surpass around US$ 15.1 billion by 2030 from valued at US$ 7.3 billion in 2020 with a CAGR of 9.6% from 2021 to 2030.
April 26, 2022
·
6 min read
1 of 1,083
Next
